1)Turner D, Ricciuto A, Lewis A, et al. STRIDE-II:An update on the selecting therapeutic targets in inflammatory bowel disease(STRIDE)Initiative of the International Organization for the Study of IBD(IOIBD):determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160:1570-1583, 2021
2)Takenaka K, Ohtsuka K, Kitazume Y, et al. Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn's disease. Gastroenterology 147:334-342, 2014
3)Takenaka K, Ohtsuka K, Kitazume Y, et al. Utility of magnetic resonance enterography for small bowel endoscopic healing in patients with Crohn's disease. Am J Gastroenterol 113:283-294, 2018
4)Kawamoto A, Takenaka K, Hibiya S, et al. Serum leucine-rich α2 glycoprotein:a novel biomarker for small bowel mucosal activity in Crohn's disease. Clin Gastroenterol Hepatol 2021[Epub ahead of print]
5)山本博徳,緒方晴彦,松本主之,他.小腸内視鏡診療ガイドライン.Gastroenterol Endosc 57:2685-2720, 2015
6)Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease:a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif(GETAID). Gut 30:983-989, 1989
7)Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease:the SES-CD. Gastrointest Endosc 60:505-512, 2004
8)Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 99:956-963, 1990
9)Takenaka K, Ohtsuka K, Kitazume Y, et al. Correlation of the endoscopic and magnetic resonance scoring systems in the deep small intestine in Crohn's disease. Inflamm Bowel Dis 21:1832-1838, 2015
10)Takenaka K, Fujii T, Suzuki K, et al. Small bowel healing detected by endoscopy in patients with Crohn's disease after treatment with antibodies against tumor necrosis factor. Clin Gastroenterol Hepatol 18:1545-1552, 2020